New study below [1].
The insulin axis is rarely talked about but is very important IMO.
Even back in 2004 there were a lot of insulin-like growth factor-I [IGF-I] studies. Currently 556 hits on PubMed for <prostate "IGF-I">. But who reads them?
I have learned to beware of anything with "growth factor" in the name, since diagnosis.
The simple view of IGF-I is that most of it is normally bound to proteins. There are various IGF binding proteins, but IGFBP-3 may be the most important one. It's common for IGF-I to be higher in PCa, and/or IGFBP-3 levels to be lower. The effect is to increase bioactive IGF-I. {IGF-I can be lowered by selective amino acid restriction - i.e. of one of the essential amino acids for building protein. The body will not commit to growth when it cannot build protein.}
In the new Boston/Montreal study, they looked at:
"Circulating Insulin-Like Growth Factor 1-Related Biomarkers and Risk of Lethal Prostate"
At first it seems that they did a bait & switch:
"Our study provides suggestive evidence that among men who later develop prostate cancer, higher plasma PAPP-A levels measured prior to diagnosis are associated with increased risk of lethal compared with indolent disease."
PAPP-A is pregnancy-associated plasma protein A. What the heck is that?
"Men in the highest quartile of PAPP-A levels had 42% higher odds of lethal prostate cancer "
Wiki: the "main substrate {for PAPP-A} is insulin-like growth factor binding proteins" [IGFBPs]. So PAPP-A is not derived from IGF-I, but from one of its binding proteins. That's one way of reducing IGFBPs.
It's good to have more pregnancy-associated plasma protein A when you are pregnant, but not so much when you are diagnosed with PCa.
Seems to me that it could be used as a biomarker for aggresive treatment. It would be good to have a heads-up at diagnosis.
From 2020 [2] we see that:
"Pregnancy-Associated Plasma Protein-A2 Is Associated With Mortality in Patients With Lung Cancer"
From 2019 [3], a link with inflammation:
"Pregnancy-Associated Plasma Protein A Induces Inflammatory Cytokine Expression by Activating IGF-I/PI3K/Akt Pathways"
-Patrick
[1] pubmed.ncbi.nlm.nih.gov/350...